SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents

Coronavirus disease 2019 (COVID-19) convalescents living in regions with low vaccination rates rely on post-infection immunity for protection against re-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We evaluate humoral and T cell immunity against five variants of conce...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Valtanen, Pablo, Hope, Christopher M., Masavuli, Makutiro G., Yeow, Arthur Eng Lip, Balachandran, Harikrishnan, Mekonnen, Zelalem A., Al-Delfi, Zahraa, Abayasingam, Arunasingam, Agapiou, David, Stella, Alberto Ospina, Aggarwal, Anupriya, Bouras, George, Gummow, Jason, Ferguson, Catherine, O’Connor, Stephanie, McCartney, Erin M., Lynn, David J., Maddern, Guy, Gowans, Eric J., Reddi, Benjamin A.J., Shaw, David, Kok-Lim, Chuan, Beard, Michael R., Weiskopf, Daniela, Sette, Alessandro, Turville, Stuart G., Bull, Rowena A., Barry, Simon C., Grubor-Bauk, Branka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110310/
https://www.ncbi.nlm.nih.gov/pubmed/35654046
http://dx.doi.org/10.1016/j.xcrm.2022.100651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110310/
https://www.ncbi.nlm.nih.gov/pubmed/35654046
http://dx.doi.org/10.1016/j.xcrm.2022.100651

Ejemplares similares